JERUSALEM, Feb 12 (Reuters) - MediWound (MDWD.O), opens new tab, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase ...

More than 70% of leg ulcers are caused by venous diseases, and their prevalence increases with age. Venous leg ulcers account for most chronic lower-limb wounds observed in primary care, underscoring ...

(RTTNews) - Biopharmaceutical company MediWound Ltd. (MDWD) Wednesday announced its partnership with 3M Health Care for the Phase 3 study of MediWound's lead drug candidate EscharEx to treat patients ...

In normal conditions, contraction of lower extremity muscles and working intraluminal valves promote the forward flow of blood within veins. In venous insufficiency, reflux and/or obstruction in the ...

A thermal-imaging tool to screen for chronic wounds could enable nurses to identify these hard-to-heal sores during the first assessment at a person's home. Nearly half a million Australians live with ...

A leg ulcer can be understood as a break in the skin, typically located on the feet or the lower part of the leg. Leg ulcers are generally diagnosed based on their appearance, though this can be ...

Compression products for treating venous leg ulcers include hosiery (socks and stockings), bandages and wraps. You should have access to compression products to treat your leg ulcer that are ...

The treatment, which consists of skin cells (keratinocytes and fibroblasts) suspended in a mixture of different types of proteins associated with blood clotting, was tested on a group of 228 patients ...

Pune, March 03, 2020 (GLOBE NEWSWIRE) -- The global Venous Leg Ulcer Treatment Market size is projected to reach USD 4.84 billion by 2026. Recent advancements in treatment options for venous leg ulcer ...

MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, for treating venous leg ulcers (VLUs). The primary aim of the trial is to ...